Cited by 325Cell death mechanisms and regulationNF-κB Signaling PathwaysDeath, Funerary Practices, and Mourning

Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis

Open access
Geng, Jiefei, Ito, Yasushi, Shi, Linyu, Amin, Palak, Chu, Jiachen, Ouchida, Amanda Tomie, Mookhtiar, Adnan Kasim, Zhao, Heng +6 more·2017·Nature Communications

Abstract

Stimulation of TNFR1 by TNFα can promote three distinct alternative mechanisms of cell death: necroptosis, RIPK1-independent and -dependent apoptosis. How cells decide which way to die is unclear. Here, we report that TNFα-induced phosphorylation of RIPK1 in the intermediate domain by TAK1 plays a key role in regulating this critical decision. Using phospho-Ser321 as a marker, we show that the transient phosphorylation of RIPK1 intermediate domain induced by TNFα leads to RIPK1-independent apoptosis when NF-κB activation is inhibited by cycloheximide. On the other hand, blocking Ser321 phosphorylation promotes RIPK1 activation and its interaction with FADD to mediate RIPK1-dependent apoptosis (RDA). Finally, sustained phosphorylation of RIPK1 intermediate domain at multiple sites by TAK1 promotes its interaction with RIPK3 and necroptosis. Thus, absent, transient and sustained levels of TAK1-mediated RIPK1 phosphorylation may represent distinct states in TNF-RSC to dictate the activation of three alternative cell death mechanisms, RDA, RIPK1-independent apoptosis and necroptosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-00406-w

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Assembly of necrosome upon TNFR1 stimulation impinges on two conditions: pharmacological or genetic CASP8 inactivation, and RIPK1 deubiquitination-dependent phosphorylation (at least in some settings), which can be favored by SMAC mimetics.

    “In addition, the assembly of the necrosome upon TNFR1 stimulation impinges on two conditions: (1) pharmacological or genetic CASP8 inactivation [478, 479], and (2) RIPK1 deubiquitination-dependent phosphorylation (at least in some settings), which can be favored by exogenously provided SMAC mimetics, ensuring the release of RIPK1 from complex I (see above) [334, 335, 480, 481].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 34 · Cited by 325

Research works printed but not linked: 1

  1. [34]Cryns VL Bergeron L Zhu H Li H Yuan J Specific cleavage of alpha-fodrin during Fas- and tumor necrosis factor-induced apoptosis is mediated by an interleukin-1beta-converting enzyme/Ced-3 protease distinct from the poly(ADP-ribose) polymerase protease J. Biol. Chem. 1996 271 31277 31282 10.1074/jbc.271.49.31277 8940132 · DOI

Authors
Geng, J., Ito, Y., Shi, L., Amin, P., Chu, J., Ouchida, A. T., Mookhtiar, A. K., Zhao, H., Xu, D., Shan, B., Najafov, A., Gao, G., Akira, S., & Yuan, J.
Affiliations
  • Harvard University (US)
  • Chinese Academy of Sciences (CN)
  • University of Massachusetts Chan Medical School (US)
  • Immunology Frontier Research Center, The University of Osaka (JP)
Corresponding author
Yuan, Junying
Venue
Nature Communications
Published
2017-08-25
Volume
8
Issue
1
Pages
359-359
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2746696507
Cited by
325
References
34
Citations by year
2026: 29 · 2025: 41 · 2024: 34 · 2023: 39 · 2022: 35 · 2021: 38 · 2020: 48 · 2019: 35 · 2018: 21 · 2017: 2 · 2012: 2
FWCI
11.85
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Science Foundation
  • Nakatomi Foundation
  • Chinese Academy of Sciences (2014ZX09102001-002)
  • Mochida Memorial Foundation for Medical and Pharmaceutical Research
  • Daiichi Sankyo Foundation of Life Science
  • National Institutes of Health (4r01ns082257-04)
  • Japan Society for the Promotion of Science
  • National Institute on Aging (R01AG047231)
  • National Institute of Neurological Disorders and Stroke (R01-NS082257, 1R01NS082257)
  • Daiichi Sankyo Europe
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Social Sciences › Anthropology › Death, Funerary Practices, and Mourning
Keywords
RIPK1, TAK1, necroptosis, TNF signaling, TNFR1, RIPK3, FADD, NF-κB
MeSH terms
MAP Kinase Kinase Kinase 7, Animals, Cells, Cultured, Cycloheximide, Phosphorylation, Tumor Necrosis Factor-alpha, NF-kappa B, Cell Death, MAP Kinase Kinase Kinases, Receptors, Tumor Necrosis Factor, Type I, Mice, Receptor-Interacting Protein Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review